Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract

NCT05439135 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2025-07-10

No results posted yet for this study

Summary

This is a prospective, randomized, multicenter study to evaluate WMT in improving nutritional status in malnourished patients who underwent nonphysiological reconstruction of the upper gastrointestinal tract. In this multicenter trial, sixty-two patients will be enrolled in forteen Chinese sites. Participants will be randomized at a ratio of 1:1 to receive three WMTs through either mid-gut tube or colonic TET. After WMT, each participant will receive free diet plus home enteral nutrition. Home enteral nutrition should last for 2 months at home, with blood, urine and stool samples taken and stored at baseline and 2 months after WMT.

Conditions

  • Malnutrition
  • Gastroenterostomy

Interventions

OTHER

washed microbiota transplantation

Each patient will receive washed microbiota transplantation each day for three consecutive days. After WMT, participants will receive free diet plus home enteral nutrition (solution at a 750ml daily dosage that provides 750 kcal energy) at home for 8 weeks.

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangdong Pharmaceutical University

    collaborator OTHER
  • Nanjing Medical University

    collaborator OTHER
  • Wuxi No. 2 People's Hospital

    collaborator OTHER
  • Jiangxi University of Chinese Medicine Affiliated Hospital

    collaborator UNKNOWN
  • Hubei Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • The Affiliated Hospital Of Southwest Medical University

    collaborator OTHER
  • Tang-Du Hospital

    collaborator OTHER
  • Huzhou Central Hospital

    collaborator OTHER
  • West China Forth University Hospital,Sichuan University

    collaborator UNKNOWN
  • The Affiliated People's hospital of Ningbo Univercity

    collaborator OTHER
  • Guangzhou First People Hospital of Guangzhou Medical University

    collaborator UNKNOWN
  • The First Affiliated Hospital of Anhui University of Chinese Medicine

    collaborator OTHER
  • Beijing Rectum Hospital

    collaborator UNKNOWN
  • Dazhou Central Hospital

    collaborator OTHER
  • The Second Affiliated Hospital of Dalian Medical University

    collaborator OTHER
  • Second Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • The 901th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army

    collaborator UNKNOWN
  • YI'AN PEOPLE'S HOSPITAL

    collaborator UNKNOWN
  • Hunan Aerospace Hospital

    collaborator UNKNOWN
  • Jiamusi City Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN
  • The First People's Hospital of Kunshan

    collaborator OTHER
  • LanZhou University

    collaborator OTHER
  • Jingxing xian yiyuan

    collaborator UNKNOWN
  • TAIHE country people's hospital

    collaborator UNKNOWN
  • Tailai County People's Hospital

    collaborator UNKNOWN
  • Armed Police Characteristic Medical Center

    collaborator UNKNOWN
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • The Second Hospital of Nanjing Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-20
Primary Completion
2025-10-31
Completion
2025-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05439135 on ClinicalTrials.gov